Long Day's Journey Into Night for Lower-Risk Myelodysplastic Syndromes

被引：2
|
作者：
Sekeres, Mikkael A. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 25期
关键词：
SCORING SYSTEM; LENALIDOMIDE; DECITABINE;
D O I：
10.1200/JCO.2016.68.2492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2956 / +
页数：4
相关论文
共 50 条
  • [1] Azacitidine in lower-risk myelodysplastic syndromes
    Santini, Valeria
    [J]. LEUKEMIA RESEARCH, 2009, 33 : S22 - S26
  • [2] Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
    Fenaux, Pierre
    Platzbecker, Uwe
    Mufti, Ghulam J.
    Garcia-Manero, Guillermo
    Buckstein, Rena
    Santini, Valeria
    Diez-Campelo, Maria
    Finelli, Carlo
    Cazzola, Mario
    Ilhan, Osman
    Sekeres, Mikkael A.
    Falantes, Jose F.
    Arrizabalaga, Beatriz
    Salvi, Flavia
    Giai, Valentina
    Vyas, Paresh
    Bowen, David
    Selleslag, Dominik
    DeZern, Amy E.
    Jurcic, Joseph G.
    Germing, Ulrich
    Goetze, Katharina S.
    Quesnel, Bruno
    Beyne-Rauzy, Odile
    Cluzeau, Thomas
    Voso, Maria-Teresa
    Mazure, Dominiek
    Vellenga, Edo
    Greenberg, Peter L.
    Hellstrom-Lindberg, Eva
    Zeidan, Amer M.
    Ades, Lionel
    Verma, Amit
    Savona, Michael R.
    Laadem, Abderrahmane
    Benzohra, Aziz
    Zhang, Jennie
    Rampersad, Anita
    Dunshee, Diana R.
    Linde, Peter G.
    Sherman, Matthew L.
    Komrokji, Rami S.
    List, Alan F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (02): : 140 - 151
  • [3] How to manage lower-risk myelodysplastic syndromes
    Sekeres, M. A.
    [J]. LEUKEMIA, 2012, 26 (03) : 390 - 394
  • [4] Lowering the boom on lower-risk myelodysplastic syndromes
    Sekeres, Mikkael A.
    Patel, Bhumika J.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 367 - 372
  • [5] Evolving therapies for lower-risk myelodysplastic syndromes
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    [J]. ANNALS OF HEMATOLOGY, 2020, 99 (04) : 677 - 692
  • [6] Management of patients with lower-risk myelodysplastic syndromes
    Andrew M. Brunner
    Heather A. Leitch
    Arjan A. van de Loosdrecht
    Nicolas Bonadies
    [J]. Blood Cancer Journal, 12
  • [7] Diagnostic algorithm for lower-risk myelodysplastic syndromes
    Mufti, Ghulam J.
    McLornan, Donal P.
    van de Loosdrecht, Arjan A.
    Germing, Ulrich
    Hasserjian, Robert P.
    [J]. LEUKEMIA, 2018, 32 (08) : 1679 - 1696
  • [8] Raising the bar for lower-risk myelodysplastic syndromes
    Venugopal, Sangeetha
    Sekeres, Mikkael A. A.
    [J]. LEUKEMIA & LYMPHOMA, 2023, 64 (06) : 1082 - 1091
  • [9] Luspatercept in the treatment of lower-risk myelodysplastic syndromes
    Chan, Onyee
    Komrokji, Rami S.
    [J]. FUTURE ONCOLOGY, 2021, 17 (12) : 1473 - 1481
  • [10] Management of patients with lower-risk myelodysplastic syndromes
    Brunner, Andrew M.
    Leitch, Heather A.
    van de Loosdrecht, Arjan A.
    Bonadies, Nicolas
    [J]. BLOOD CANCER JOURNAL, 2022, 12 (12)
12345